1606 Corp. Now Trading on OTC Under Symbol “CBDW” Company Formed as a 1-for-1 distribution […]
Lichen China Limited Announces Pricing of US$16 Million Initial Public Offering
JINJIANG, China, Feb. 6, 2023 — Lichen China Limited (the “Company” or “Lichen China”), […]
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
SHANGHAI, Feb. 4, 2023 — Qiming Venture Partners’ portfolio company Structure Therapeutics Inc. (NASDAQ: […]
Financiera Independencia Announces Early Results and Extension of the Early Exchange Payment for its Exchange Offer for Any and All of its 8.000% Senior Notes due 2024 and Related Consent Solicitation
MEXICO CITY, Feb. 3, 2023 — Financiera Independencia, S.A.B. de C.V., Sociedad Financiera de […]
DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants
CUPERTINO, Calif., Feb. 3, 2023 — DURECT Corporation (Nasdaq: DRRX) (“DURECT”), a biopharmaceutical company […]
mCloud Provides Update on Financing Activities
SAN FRANCISCO, Feb. 3, 2023 – mCloud Technologies Corp. (Nasdaq: MCLD) (TSXV: MCLD), (“mCloud” […]
Pyxus Announces Expiration and Final Results of its Previously Announced Exchange Offer and Consent Solicitation
MORRISVILLE, N.C., Feb. 3, 2023 — Pyxus International, Inc. (OTC Pink: PYYX) (the “Company”), […]
Interview Valet Unveils Its Most Anticipated Resource: 2023 State of Podcast Guesting Annual Report
KALAMAZOO, Mich., Feb. 3, 2023 — Interview Valet, a leading provider of podcast interview […]
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BRIDGEWATER, N.J., Feb. 3, 2023 — Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on […]